Diabetes remission after nonsurgical intensive lifestyle intervention in obese patients with type 2 diabetes

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Mottalib, Adham ^a   Sakr, Mahmoud ^a   Shehabeldin, Mohamed ^a   Hamdy, Osama ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; LIPID; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; FOLLOW UP; GLYCEMIC CONTROL; HEALTH PROGRAM; HUMAN; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; WEIGHT REDUCTION; BLOOD; COGNITIVE THERAPY; COMBINATION DRUG THERAPY; COMPLICATION; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DRUG MONITORING; EXERCISE; HYPERGLYCEMIA; LIFESTYLE; LOW CALORY DIET; MASSACHUSETTS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT EDUCATION; PERSONALIZED MEDICINE; RANDOMIZED CONTROLLED TRIAL;

BODY MASS INDEX; BOSTON; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; DRUG MONITORING; DRUG THERAPY, COMBINATION; EXERCISE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; LIFE STYLE; MIDDLE AGED; OBESITY; PATIENT EDUCATION AS TOPIC; PRECISION MEDICINE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84934944936     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/468704     Document Type: Article

References (27)

1. D. M. Nathan, "Long-term complications of diabetes mellitus, " The New England Journal ofMedicine, vol. 328, no. 23, pp. 1676-1685, 1993.
2. G. Mingrone, S. Panunzi, A. de Gaetano et al., "Bariatric surgery versus conventional medical therapy for type 2 diabetes, " The New England Journal ofMedicine, vol. 366, no. 17, pp. 1577-1585, 2012.
3. H. Buchwald, R. Estok, K. Fahrbach et al., "Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis, " The American Journal of Medicine, vol. 122, no. 3, pp. 248.e5-256.e5, 2009.
4. G. A. Colditz, W. C. Willett, A. Rotnitzky, and J. E. Manson, "Weight gain as a risk factor for clinical diabetes mellitus in women, "Annals of InternalMedicine, vol. 122, no. 7, pp. 481-486, 1995.
5. J. W. Anderson, C.W. C. Kendall, and D. J. A. Jenkins, "Importance of weight management in Type 2 diabetes: review with meta-analysis of clinical studies, " Journal of the American College of Nutrition, vol. 22, no. 5, pp. 331-339, 2003.
6. O. Hamdy, S. Ledbury, C. Mullooly et al., "Lifestylemodification improves endothelial function in obese subjects with the insulin resistance syndrome, " Diabetes Care, vol. 26, no. 7, pp.2119-2125, 2003.
7. L. U. Monzillo, O. Hamdy, E. S. Horton et al., "Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance, " Obesity Research, vol. 11, no. 9, pp. 1048-1054, 2003.
8. L. Aucott, A. Poobalan, W. C. S. Smith et al., "Weight loss in obese diabetic and non-diabetic individuals and long-termdiabetes outcomes-a systematic review, " Diabetes, Obesity and Metabolism, vol. 6, no. 2, pp. 85-94, 2004.
9. L. Sjöström, A.-K. Lindroos, M. Peltonen et al., "Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery, "The New England Journal of Medicine, vol. 351, no. 26, pp. 2683-2693, 2004.
10. O. Hamdy, "Diabetes weight management in clinical practice-the why wait model, " US Endocrinology, vol. 4, no. 2, pp. 49-54, 2008.
11. J. B. Buse, S. Caprio, W. T. Cefalu et al., "How do we define cure of diabetes?" Diabetes Care, vol. 32, no. 11, pp. 2133-2135, 2009.
12. O. Hamdy and C. Carver, "The whyWAIT program: improving clinical outcomes through weight management in type 2 diabetes, " Current Diabetes Reports, vol. 8, no. 5, pp. 413-420, 2008.
13. E. W. Gregg, H. Chen, L. E. Wagenknecht et al., "Association of an intensive lifestyle intervention with remission of type 2 diabetes, " Journal of the AmericanMedical Association, vol. 308, no. 23, pp. 2489-2496, 2012.
14. R.R. Wing, J. L. Bahnson, G. A. Bray et al., "Long-termeffects of a lifestyle intervention onweight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the look AHEAD trial, " Archives of Internal Medicine, vol. 170, no. 17, pp. 1566-1575, 2010.
15. E. W. Gregg, M. P. Kyithar, and S. F. Dinneen, "Acp journal club: an intensive lifestyle intervention increased remission from type 2 diabetes in overweight adults, " Annals of Internal Medicine, vol. 158, no. 10, article JC4, 2013.
16. R. A. Defronzo, "From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus, " Diabetes, vol. 58, no. 4, pp. 773-795, 2009.
17. R. C. Turner, J. I. Mann, R. R. Holman et al., "UK prospective diabetes study. V. Characteristics of newly presenting type 2 diabetic patients: estimated insulin sensitivity and islet B-cell function, " Diabetic Medicine, vol. 5, no. 5, pp. 444-448, 1988.
18. R.N. Bergman, L. S. Phillips, and C. Cobelli, "Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and -cell glucose sensitivity from the response to intravenous glucose, " The Journal of Clinical Investigation, vol. 68, no. 6, pp. 1456-1467, 1981.
19. S. E. Kahn, R. L. Prigeon, D. K. McCulloch et al., "Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function, " Diabetes, vol. 42, no. 11, pp. 1663-1672, 1993.
20. A. H. Xiang, R. K. Peters, S. L. Kjos et al., "Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and β-cell function, " The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 6, pp. 2846-2851, 2004.
21. R. C. Turner, J. I. Mann, G. Iceton et al., "UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year, " Diabetologia, vol. 24, no. 6, pp. 404-411, 1983.
22. S. Cernea and M. Dobreanu, "Diabetes and beta cell function: from mechanisms to evaluation and clinical implications, " Biochemia Medica, vol. 23, no. 3, pp. 266-280, 2013.
23. D. M. Nathan, J. B. Buse, M. B. Davidson et al., "Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the american diabetes association and the european association for the study of diabetes, " Diabetes Care, vol. 32, no. 1, pp. 193-203, 2009.
24. "Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial, " The American Journal of Cardiology, vol. 75, no. 14, pp. 894-903, 1995.
25. L. Sjöström, "Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study, " International Journal of Obesity, vol. 32, no. 7, pp. S93-S97, 2008.
26. N. Puzziferri, T. B. Roshek, H. G. Mayo, R. Gallagher, S. H. Belle, and E.H. Livingston, "Long-termfollow-up after bariatric surgery: a systematic review, " The Journal of the American Medical Association, vol. 312, no. 9, pp. 934-942, 2014.
27. S.N. Bleich, H. Y. Chang, B. Lau et al., "Impact of bariatric surgery on health care utilization and costs among patients with diabetes, " Medical Care, vol. 50, pp. 58-65, 2012.